1INN — innoscripta SE Income Statement
0.000.00%
Last trade - 00:00- €1.10bn
- €1.07bn
- €64.71m
- 44
- 10
- 67
- 30
Annual income statement for innoscripta SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | GAS | GAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 39.4 | 64.7 |
| Cost of Revenue | ||
| Gross Profit | 38 | 63.3 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 23.9 | 27.4 |
| Operating Profit | 15.5 | 37.3 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | 15.5 | 37.4 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 10.3 | 25.1 |
| Net Income Before Extraordinary Items | ||
| Net Income | 10.3 | 25.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 10.3 | 25.1 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 1.03 | 2.51 |